303 related articles for article (PubMed ID: 24120728)
1. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
Araújo F; Sarmento B
Int J Pharm; 2013 Dec; 458(1):128-34. PubMed ID: 24120728
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture.
Lozoya-Agullo I; Araújo F; González-Álvarez I; Merino-Sanjuán M; González-Álvarez M; Bermejo M; Sarmento B
Mol Pharm; 2017 Apr; 14(4):1264-1270. PubMed ID: 28263609
[TBL] [Abstract][Full Text] [Related]
3. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
[TBL] [Abstract][Full Text] [Related]
4. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
Antunes F; Andrade F; Araújo F; Ferreira D; Sarmento B
Eur J Pharm Biopharm; 2013 Apr; 83(3):427-35. PubMed ID: 23159710
[TBL] [Abstract][Full Text] [Related]
6. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
[TBL] [Abstract][Full Text] [Related]
7. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design.
Chen XM; Elisia I; Kitts DD
J Pharmacol Toxicol Methods; 2010; 61(3):334-42. PubMed ID: 20159047
[TBL] [Abstract][Full Text] [Related]
8. Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies.
Pereira C; Araújo F; Barrias CC; Granja PL; Sarmento B
Biomaterials; 2015 Jul; 56():36-45. PubMed ID: 25934277
[TBL] [Abstract][Full Text] [Related]
9. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
[TBL] [Abstract][Full Text] [Related]
10. Intestinal transport of methylmercury and inorganic mercury in various models of Caco-2 and HT29-MTX cells.
Vázquez M; Calatayud M; Vélez D; Devesa V
Toxicology; 2013 Sep; 311(3):147-53. PubMed ID: 23793072
[TBL] [Abstract][Full Text] [Related]
11. Oleic Acid Uptake Reveals the Rescued Enterocyte Phenotype of Colon Cancer Caco-2 by HT29-MTX Cells in Co-Culture Mode.
Berger E; Nassra M; Atgié C; Plaisancié P; Géloën A
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726765
[TBL] [Abstract][Full Text] [Related]
12. Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials.
Ude VC; Brown DM; Stone V; Johnston HJ
J Nanobiotechnology; 2019 May; 17(1):70. PubMed ID: 31113462
[TBL] [Abstract][Full Text] [Related]
13. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation.
Li N; Wang D; Sui Z; Qi X; Ji L; Wang X; Yang L
Tissue Eng Part C Methods; 2013 Sep; 19(9):708-19. PubMed ID: 23350801
[TBL] [Abstract][Full Text] [Related]
14. 3D Model Replicating the Intestinal Function to Evaluate Drug Permeability.
Pereira I; Lechanteur A; Sarmento B
Methods Mol Biol; 2018; 1817():107-113. PubMed ID: 29959707
[TBL] [Abstract][Full Text] [Related]
15. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
16. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans.
Walter E; Janich S; Roessler BJ; Hilfinger JM; Amidon GL
J Pharm Sci; 1996 Oct; 85(10):1070-6. PubMed ID: 8897273
[TBL] [Abstract][Full Text] [Related]
17. Different responses of Fe transporters in Caco-2/HT29-MTX cocultures than in independent Caco-2 cell cultures.
Laparra JM; Glahn RP; Miller DD
Cell Biol Int; 2009 Sep; 33(9):971-7. PubMed ID: 19524686
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
19. In-vitro investigation regarding the effects of Gelucire
Dubray O; Jannin V; Demarne F; Pellequer Y; Lamprecht A; Béduneau A
Int J Pharm; 2016 Dec; 515(1-2):293-299. PubMed ID: 27720954
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability.
Mahler GJ; Shuler ML; Glahn RP
J Nutr Biochem; 2009 Jul; 20(7):494-502. PubMed ID: 18715773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]